A child-friendly formulation of the antiretroviral drug dolutegravir was first included in the country’s HIV treatment guidelines in 2023. New estimates suggest that most children aged one to four living with HIV have now been switched to the drug, reports Elri Voigt.
Health research in South Africa has been plunged into crisis with the abrupt termination of several large research grants from the US, with more grant terminations expected in the coming days and weeks. Professor Ntobeko Ntusi, head of the South African Medical Research Council, tells Spotlight about efforts to find alternative funding and to preserve the country’s health research capacity.
Medical researchers in South Africa are in limbo as they wait to hear whether over R800 million in research grants from the United States National Institutes of Health will be terminated. South Africa’s top universities, which receive the bulk of the funding, will be particularly hard hit if the cuts materialise. Catherine Tomlinson reports.
The World Health Organization in February this year said that an estimated 1.1 million new cancer cases are being reported in Africa each year with around 700 000 deaths from cancer. A recent report provides important new data on cancer in South Africa, but the picture remains incomplete. Ufrieda Ho reports.
South Africa’s HIV testing programme has been a huge success over the last decade, largely due to the use of rapid tests. Now, the introduction of a new generation of rapid tests may offer some benefits over the current tests, but the picture is somewhat complicated and the Department of Health is not currently planning to use the new tests. Amy Green investigates.
Professor Wendy Stevens believes ‘completely in the honesty of science’ and this, she says, has landed her in the naughty corner many times throughout her career. Biénne Huisman spoke to the global leader in HIV and TB laboratory medicine about her career, what you choose when science and politics collide, and the value of swimming upstream.
